ArkansasTO MANDATE THE USE OF BIOSIMILAR MEDICINES UNDER HEALTH BENEFIT PLANS; TO REQUIRE A HEALTHCARE PROVIDER TO PRESCRIBE BIOSIMILAR MEDICINES; AND TO IMPROVE ACCESS TO BIOSIMILAR MEDICINES.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2025
- May 5Sine Die adjournmentLatest
- Apr 1Recommended for study in the Interim Committee on INSURANCE & COMMERCE - SENATE
- Apr 1Withdrawn from Committee and placed on calendar.
- Mar 10Re-referred to INSURANCE & COMMERCE - SENATEMinor
- Mar 10REPORTED CORRECTLY ENGROSSED
- Mar 10Amendment # 2 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
- Mar 10Withdrawn from Committee and placed on 2nd reading for purpose of amendment # 2
- Feb 5Re-referred to INSURANCE & COMMERCE - SENATEMinor
- Feb 5REPORTED CORRECTLY ENGROSSED
- Feb 5Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
- Feb 5Withdrawn from Committee and placed on 2nd reading for purpose of amendment # 1
- Jan 29Read first time, rules suspended, read second time, referred to INSURANCE & COMMERCE - SENATEMinor
- Jan 29FiledIntroduced